SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-23-102767
Filing Date
2023-04-17
Accepted
2023-04-17 06:08:27
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-C d496988dsctoc.htm SC TO-C 14561
2 EX-99.1 d496988dex991.htm EX-99.1 14480
3 EX-99.2 d496988dex992.htm EX-99.2 40672
4 GRAPHIC g496988g0416235329316.jpg GRAPHIC 1751
5 GRAPHIC g496988g0416235329503.jpg GRAPHIC 2545
  Complete submission text file 0001193125-23-102767.txt   77554
Mailing Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394
Business Address 2438 MIYANOURA-MACHI KAGOSHIMA CITY KAGOSHIMA M0 891-1394 81-99-294-2600
Shin Nippon Biomedical Laboratories, Ltd. (Filed by) CIK: 0001657770 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC TO-C

Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-91126 | Film No.: 23822740
SIC: 2834 Pharmaceutical Preparations